| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.959 | 1 | 1 | 1984 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 1 | 5 | 1988 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.927 | 1 | 1 | 1998 | 2020 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.430 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
CD69 molecule | 0.488 | 0.923 | 3.0E-02 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
protein kinase C theta | 0.636 | 0.654 | 0.30 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2008 | 2009 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.200 | None | 0.882 | 1 | 1 | 1990 | 2017 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.946 | 1 | 1 | 1980 | 2020 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.929 | 1 | 4 | 1991 | 2014 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 0.964 | 1 | 17 | 1982 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 2 | 0.573 | 0.731 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 7 | 1990 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1999 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 4 | 1986 | 2019 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.200 | None | 0.917 | 1 | 1 | 1979 | 2015 | ||||||||
|
MHC class I polypeptide-related sequence A | 0.473 | 0.846 | 5.0E-03 |
|
disease | 0.200 | None | 0.893 | 1 | 1 | 1995 | 2012 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.200 | None | 0.800 | 1 | 12 | 1993 | 2015 | ||||||||
|
transporter 1, ATP binding cassette subfamily B member | 0.500 | 0.808 | 5.3E-06 |
|
disease | 0.200 | None | 0.938 | 1 | 3 | 1993 | 2014 | ||||||||
|
CD226 molecule | 0.548 | 0.769 | 3.9E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2007 | 2015 | ||||||||
|
ribosomal protein S26 | 0.716 | 0.538 | 0.85 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2008 | 2015 | ||||||||
|
transcription factor 19 | 0.674 | 0.692 | 9.4E-04 |
|
disease | 0.140 | None | 1.000 | 1 | 2 | 2007 | 2020 | ||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 1992 | 2010 | ||||||||
|
gasdermin B | 0.670 | 0.500 | 3.3E-07 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2009 | 2016 | ||||||||
|
proteasome 20S subunit beta 9 | 0.514 | 0.808 | 2.7E-03 |
|
disease | 0.130 | None | 1.000 | 1 | 5 | 1994 | 2007 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.130 | None | 0.750 | 1 | 3 | 1995 | 2018 | ||||||||
|
proteasome 20S subunit beta 8 | 0.533 | 0.808 | 2.2E-02 |
|
disease | 0.130 | None | 1.000 | 1 | 3 | 1995 | 2011 |